ROIV Roivant Sciences PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ROIV
- PE Ratio
The current PE ratio of ROIV can't be determined, as the TTM EPS of -$0.7 is negative. The last PE ratio of Roivant Sciences, recorded in September 2024, was 1.94.
ROIV PE ratio history
How has ROIV's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A
Roivant Sciences PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $10.09 | -$0.24 |
| 2024 | 1.9 | N/A | $10.54 | $5.55 |
| 2023 | N/A | N/A | $7.38 | -$1.42 |
| 2022 | N/A | N/A | $4.94 | -$1.26 |
| 2021 | N/A | N/A | $9.78 | -$1.28 |
| 2020 | N/A | N/A | N/A | $5.13 |
Roivant Sciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | N/A | N/A | $11.27 | -$0.7 |
| Mar 2025 | N/A | N/A | $10.09 | -$0.24 |
| Dec 2024 | N/A | N/A | $11.83 | -$0.19 |
| Sep 2024 | 1.94 | 7.78% | $11.54 | $5.95 |
| Jun 2024 | 1.8 | -5.26% | $10.57 | $5.86 |
| Mar 2024 | 1.9 | -5.94% | $10.54 | $5.55 |
| Dec 2023 | 2.02 | N/A | $11.23 | $5.56 |
| Sep 2023 | N/A | N/A | $11.68 | -$1.3 |
| Jun 2023 | N/A | N/A | $10.08 | -$1.32 |
| Mar 2023 | N/A | N/A | $7.38 | -$1.42 |
| Dec 2022 | N/A | N/A | $7.99 | -$1.78 |
| Sep 2022 | N/A | N/A | $3.22 | -$1.7 |
| Jun 2022 | N/A | N/A | $4.07 | -$1.6 |
| Mar 2022 | N/A | N/A | $4.94 | -$1.26 |
| Dec 2021 | N/A | N/A | $10.08 | -$1.66 |
ROIV Price vs fair value
How does ROIV's price compare to its estimated fair value based on its growth
ROIV average PE ratio chart
What is the average PE ratio of ROIV for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A
ROIV PE vs peers
What is ROIV's PE ratio compared to its peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OLMA Olema Pharmaceuticals Inc | N/A | $378.18M |
| OMER Omeros Corp | N/A | $300.13M |
| VIVS VivoSim Labs Inc. | N/A | $4.6M |
| ORIC Oric Pharmaceuticals Inc | N/A | $938.21M |
| ORMP Oramed Pharmaceuticals Inc | N/A | $85.29M |
| ROIV Roivant Sciences Ltd | N/A | $8.09B |
Frequently asked questions
What is Roivant Sciences's PE ratio?
The current price to earnings ratio of ROIV can't be calculated, as its EPS of -$0.7 is negative.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.